134 related articles for article (PubMed ID: 10627914)
21. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts.
Valyasevi RW; Harteneck DA; Dutton CM; Bahn RS
J Clin Endocrinol Metab; 2002 May; 87(5):2352-8. PubMed ID: 11994387
[TBL] [Abstract][Full Text] [Related]
23. Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.
Baker G; Mazziotti G; von Ruhland C; Ludgate M
Endocrinology; 2005 Feb; 146(2):835-44. PubMed ID: 15542454
[TBL] [Abstract][Full Text] [Related]
24. Analysis of retroorbital T cell antigen receptor variable region gene usage in patients with Graves' ophthalmopathy.
Heufelder AE; Herterich S; Ernst G; Bahn RS; Scriba PC
Eur J Endocrinol; 1995 Mar; 132(3):266-77. PubMed ID: 7889172
[TBL] [Abstract][Full Text] [Related]
25. Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves' ophthalmopathy.
Heufelder AE; Bahn RS
Eur J Clin Invest; 1993 Jan; 23(1):10-7. PubMed ID: 8444271
[TBL] [Abstract][Full Text] [Related]
26. The putative role of fibroblasts in the pathogenesis of Graves' disease: evidence for the involvement of the insulin-like growth factor-1 receptor in fibroblast activation.
Smith TJ
Autoimmunity; 2003; 36(6-7):409-15. PubMed ID: 14669949
[TBL] [Abstract][Full Text] [Related]
27. Demonstration of thyrotropin receptor mRNA in orbital fat and eye muscle tissues from patients with Graves' ophthalmopathy by in situ hybridization.
Wu SL; Yang CS; Wang HJ; Liao CL; Chang TJ; Chang TC
J Endocrinol Invest; 1999 Apr; 22(4):289-95. PubMed ID: 10342363
[TBL] [Abstract][Full Text] [Related]
28. Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue.
Spitzweg C; Joba W; Hunt N; Heufelder AE
Eur J Endocrinol; 1997 Jun; 136(6):599-607. PubMed ID: 9225723
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression.
Salvi M; Vannucchi G; Campi I; Rossi S; Bonara P; Sbrozzi F; Guastella C; Avignone S; Pirola G; Ratiglia R; Beck-Peccoz P
Eur J Endocrinol; 2006 Apr; 154(4):511-7. PubMed ID: 16556712
[TBL] [Abstract][Full Text] [Related]
30. Pathogenesis of Graves' ophthalmopathy.
Spitzweg C; Heufelder AE
Int Arch Allergy Immunol; 1997 Sep; 114(1):101-2. PubMed ID: 9303340
[No Abstract] [Full Text] [Related]
31. Fenofibrate increases the expression of high mobility group AT-hook 2 (HMGA2) gene and induces adipocyte differentiation of orbital fibroblasts from Graves' ophthalmopathy.
Pasquali D; Pierantoni GM; Fusco A; Staibano S; Colantuoni V; De Bellis A; Bellastella A; Sinisi AA
J Mol Endocrinol; 2004 Aug; 33(1):133-43. PubMed ID: 15291748
[TBL] [Abstract][Full Text] [Related]
32. CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.
Xia N; Zhou S; Liang Y; Xiao C; Shen H; Pan H; Deng H; Wang N; Li QQ
Int J Mol Med; 2006 May; 17(5):911-6. PubMed ID: 16596280
[TBL] [Abstract][Full Text] [Related]
33. TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathy.
Bahn RS
J Endocrinol Invest; 2004 Mar; 27(3):216-20. PubMed ID: 15164996
[TBL] [Abstract][Full Text] [Related]
34. Involvement of the orbital fibroblast and TSH receptor in the pathogenesis of Graves' ophthalmopathy.
Heufelder AE
Thyroid; 1995 Aug; 5(4):331-40. PubMed ID: 7488878
[TBL] [Abstract][Full Text] [Related]
35. Graves' ophthalmopathy: what is the initial abnormality?
Burman KD
Eur J Endocrinol; 1997 Jun; 136(6):583-5. PubMed ID: 9225718
[No Abstract] [Full Text] [Related]
36. Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy.
de Carli M; D'Elios MM; Mariotti S; Marcocci C; Pinchera A; Ricci M; Romagnani S; del Prete G
J Clin Endocrinol Metab; 1993 Nov; 77(5):1120-4. PubMed ID: 8077301
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of antigen receptor variable region repertoires in T lymphocytes infiltrating the intrathyroidal and extrathyroidal manifestations in patients with Graves' disease.
Heufelder AE; Schworm HD; Wenzel BE; Garrity JA; Bahn RS
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():84-7. PubMed ID: 8981009
[TBL] [Abstract][Full Text] [Related]
38. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
Gerding MN; van der Meer JW; Broenink M; Bakker O; Wiersinga WM; Prummel MF
Clin Endocrinol (Oxf); 2000 Mar; 52(3):267-71. PubMed ID: 10718823
[TBL] [Abstract][Full Text] [Related]
39. Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy.
Boschi A; Daumerie Ch; Spiritus M; Beguin C; Senou M; Yuksel D; Duplicy M; Costagliola S; Ludgate M; Many MC
Br J Ophthalmol; 2005 Jun; 89(6):724-9. PubMed ID: 15923509
[TBL] [Abstract][Full Text] [Related]
40. Cell-mediated or humoral immunity in Graves' ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue.
McLachlan SM; Prummel MF; Rapoport B
J Clin Endocrinol Metab; 1994 May; 78(5):1070-4. PubMed ID: 8175962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
